Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-12 1:29 pm Purchase | 13G | PureTech Health plc PRTC | CITIGROUP INC C | 12,004,514 5.010% | 12,004,514 (New Position) | View |
| 2024-11-07 09:47 am Sale | 13G | PureTech Health plc PRTC | Invesco Ltd. IVZ | 41,011,890 17.100% | -23,513,361 (-36.44%) | View |
| 2024-07-09 08:05 am Sale | 13D | Akili Inc. AKLI | PureTech Health plc PRTC | 0 0.000% | -12,527,477 (Position Closed) | View |
| 2024-05-30 08:05 am Unchanged | 13D | Akili Inc. AKLI | PureTech Health plc PRTC | 12,527,477 15.900% | 0 (Unchanged) | View |
| 2024-02-12 4:48 pm Sale | 13G | PureTech Health plc PRTC | Invesco Ltd. IVZ | 64,525,251 23.700% | -564,629 (-0.87%) | View |
| 2023-02-09 7:34 pm Sale | 13G | PureTech Health plc PRTC | Invesco Ltd. IVZ | 65,089,880 23.400% | -2,445,066 (-3.62%) | View |
| 2022-08-30 4:48 pm Purchase | 13D | Akili Inc. AKLI | PureTech Health plc PRTC | 12,527,477 14.700% | 12,527,477 (New Position) | View |
| 2022-02-11 12:32 pm Sale | 13G | PureTech Health plc PRTC | Invesco Ltd. IVZ | 67,534,946 23.500% | -12,695,067 (-15.82%) | View |
| 2021-02-16 3:52 pm Purchase | 13G | PureTech Health plc PRTC | Invesco Ltd. IVZ | 80,230,013 28.070% | 80,230,013 (New Position) | View |
| 2021-02-10 06:15 am Purchase | 13D | Karuna Therapeutics Inc. KRTX | PureTech Health plc PRTC | 2,406,564 9.000% | 2,406,564 (New Position) | View |